Takeda Pharmaceutical (TAK) Property, Plant & Equipment (Net) (2017 - 2026)

Takeda Pharmaceutical (TAK) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 37.35 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 4.00 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 3.72 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 13.52 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 1.84 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 49,000.00
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 2.53 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 90.90 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.40 Bn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 232.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.52 Bn
Mar 31, 2026 13.52 Bn
Dec 31, 2025 13.54 Bn
Dec 31, 2025 13.54 Bn
Sep 30, 2025 13.47 Bn
Sep 30, 2025 13.47 Bn
Jun 30, 2025 13.52 Bn
Jun 30, 2025 13.52 Bn
Mar 31, 2025 12.90 Bn
Mar 31, 2025 12.90 Bn
Dec 31, 2024 13.27 Bn
Dec 31, 2024 13.27 Bn
Sep 30, 2024 12.65 Bn
Sep 30, 2024 12.65 Bn
Jun 30, 2024 13.40 Bn
Jun 30, 2024 13.40 Bn
Mar 31, 2024 13.43 Bn
Mar 31, 2024 13.43 Bn
Dec 31, 2023 12.46 Bn
Dec 31, 2023 12.46 Bn